BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 28667800)

  • 1. Lasp2 enhances tumor invasion via facilitating phosphorylation of FAK and predicts poor overall survival of non-small cell lung cancer patients.
    Zhang X; Cai L; Zhou H; Liu Y; Fan C; Wang L; Li A; Miao Y; Li Q; Qiu X; Wang E
    Mol Carcinog; 2017 Dec; 56(12):2558-2565. PubMed ID: 28667800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LASP2 suppresses colorectal cancer progression through JNK/p38 MAPK pathway meditated epithelial-mesenchymal transition.
    Wang B; Zhang L; Zhao L; Zhou R; Ding Y; Li G; Zhao L
    Cell Commun Signal; 2017 Jun; 15(1):21. PubMed ID: 28606091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lasp1 promotes malignant phenotype of non-small-cell lung cancer via inducing phosphorylation of FAK-AKT pathway.
    Zhang X; Liu Y; Fan C; Wang L; Li A; Zhou H; Cai L; Miao Y; Li Q; Qiu X; Wang E
    Oncotarget; 2017 Sep; 8(43):75102-75113. PubMed ID: 29088849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of LIM and SH3 protein 1 in renal clear cell carcinoma and its effects on invasion and migration of renal clear cell carcinoma 786-O cells].
    Jin B; Gao L; Li W; Chen JC; Wen RM; Wang JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Mar; 39(3):166-171. PubMed ID: 28316213
    [No Abstract]   [Full Text] [Related]  

  • 5. Knockdown of LASP2 inhibits the proliferation, migration, and invasion of cervical cancer cells.
    Zhang Y; Zhang L
    J Cell Biochem; 2019 Sep; 120(9):15389-15396. PubMed ID: 31026088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ZNF452 facilitates tumor proliferation and invasion via activating AKT-GSK3β signaling pathway and predicts poor prognosis of non-small cell lung cancer patients.
    Zhang X; Zhou H; Zhang Y; Cai L; Jiang G; Li A; Miao Y; Li Q; Qiu X; Wang E
    Oncotarget; 2017 Jun; 8(24):38863-38875. PubMed ID: 28418919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kctd20 promotes the development of non-small cell lung cancer through activating Fak/AKT pathway and predicts poor overall survival of patients.
    Zhang X; Zhou H; Cai L; Fan C; Liu Y; Wang L; Li Q; Miao Y
    Mol Carcinog; 2017 Sep; 56(9):2058-2065. PubMed ID: 28398603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of LASP2 inhibits pancreatic cancer cell migration and invasion through suppressing TGF-β-induced EMT.
    Zhang Y; Li JH; Yuan QG; Cao G; Yang WB
    J Cell Biochem; 2019 Aug; 120(8):13651-13657. PubMed ID: 30945341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LINC01503/miR-342-3p facilitates malignancy in non-small-cell lung cancer cells via regulating LASP1.
    Shen Q; Sun Y; Xu S
    Respir Res; 2020 Sep; 21(1):235. PubMed ID: 32938459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIMM50 promotes tumor progression via ERK signaling and predicts poor prognosis of non-small cell lung cancer patients.
    Zhang X; Han S; Zhou H; Cai L; Li J; Liu N; Liu Y; Wang L; Fan C; Li A; Miao Y
    Mol Carcinog; 2019 May; 58(5):767-776. PubMed ID: 30604908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIM44 promotes proliferation and metastasis in non‑small cell lung cancer via mTOR signaling pathway.
    Xing Y; Meng Q; Chen X; Zhao Y; Liu W; Hu J; Xue F; Wang X; Cai L
    Oncotarget; 2016 May; 7(21):30479-91. PubMed ID: 27058415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LASP2 functions as a potential prognostic factor and therapeutic target in nasopharyngeal carcinoma.
    Yang YT; Nie LM; Wei QF; Li WZ
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9416-9422. PubMed ID: 33015783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LASP2 inhibits trophoblast cell migration and invasion in preeclampsia through inactivation of the Wnt/β-catenin signaling pathway.
    Chen L; Wang J; Fan X; Zhang Y; Zhoua M; Li X; Wang L
    J Recept Signal Transduct Res; 2021 Feb; 41(1):67-73. PubMed ID: 32635793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SRPX2 promotes cell proliferation and invasion via activating FAK/SRC/ERK pathway in non-small cell lung cancer.
    Li X; Liu J; Sun H; Zou Y; Chen J; Chen Y; Chen C; Wu X
    Acta Biochim Pol; 2020 Jun; 67(2):165-172. PubMed ID: 32550700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LIM and SH3 protein 1 induces glioma growth and invasion through PI3K/AKT signaling and epithelial-mesenchymal transition.
    Zhong C; Li X; Tao B; Peng L; Peng T; Yang X; Xia X; Chen L
    Biomed Pharmacother; 2019 Aug; 116():109013. PubMed ID: 31146105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPS5 and LASP1 synergistically interact to downregulate 14-3-3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway.
    Zhou R; Shao Z; Liu J; Zhan W; Gao Q; Pan Z; Wu L; Xu L; Ding Y; Zhao L
    Int J Cancer; 2018 May; 142(9):1853-1864. PubMed ID: 29226323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-218 inhibits the proliferation, migration, and invasion and promotes apoptosis of gastric cancer cells by targeting LASP1.
    Wang LL; Wang L; Wang XY; Shang D; Yin SJ; Sun LL; Ji HB
    Tumour Biol; 2016 Nov; 37(11):15241-15252. PubMed ID: 27696291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
    Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
    Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ROCK1 promotes migration and invasion of non‑small‑cell lung cancer cells through the PTEN/PI3K/FAK pathway.
    Hu C; Zhou H; Liu Y; Huang J; Liu W; Zhang Q; Tang Q; Sheng F; Li G; Zhang R
    Int J Oncol; 2019 Oct; 55(4):833-844. PubMed ID: 31485605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytosolic TMEM88 promotes invasion and metastasis in lung cancer cells by binding DVLS.
    Zhang X; Yu X; Jiang G; Miao Y; Wang L; Zhang Y; Liu Y; Fan C; Lin X; Dong Q; Han Q; Zhao H; Han Y; Han X; Rong X; Ding S; Wang E; Wang E
    Cancer Res; 2015 Nov; 75(21):4527-37. PubMed ID: 26359454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.